Artículos relacionados
Área salud
Mortality Outcomes in Patients With Plaque Psoriasis and Hidradenitis Suppurativa: The Role of Biologic Therapy
marzo 26, 2026
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 117. Núm. 2. (Febrero 2026)
Background and objectives Plaque psoriasis (Pso) and hidradenitis suppurativa (HS) are chronic inflammatory diseases associated with multiple comorbidities, including cardiovascular conditions, which may negatively impact survival. The aim of this study was to analyze mortality […]
Área salud
The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study
enero 15, 2024
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 9. (Octubre 2023)
Background Hidradenitis suppurativa (HS) is a chronic skin condition causing lesions in which high levels of interleukin (IL)-23 and T-helper 17 cells are found. Adalimumab remains the only approved treatment. Guselkumab, an antibody targeting the […]
